Results 281 to 290 of about 5,533,099 (347)

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Joint profiling of cell morphology and gene expression during in vitro neurodevelopment. [PDF]

open access: yesElife
Sundaresh A   +7 more
europepmc   +1 more source

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. [PDF]

open access: yesBlood
Newton NM   +11 more
europepmc   +1 more source

Updated transient gene expression protocol in Expi293F cells using PEI. [PDF]

open access: yesFront Bioeng Biotechnol
Hederoth G   +7 more
europepmc   +1 more source

Sex-Specific Gene Expression Differences in Varicose Veins. [PDF]

open access: yesBiomedicines
Smetanina MA   +6 more
europepmc   +1 more source

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma. [PDF]

open access: yesBlood Adv
Ramsower CA   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy